This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Editas Medicine, Inc.. Active years: 2022-2024.
Company Filing History:
Years Active: 2022-2024
Title: Dawn Ciulla: Innovator in Nuclease Analysis
Introduction
Dawn Ciulla is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of molecular biology, particularly in the analysis of nucleases. With a total of 2 patents, her work has advanced the understanding of gene editing technologies.
Latest Patents
Dawn's latest patents include innovative methods for assessing nuclease cleavage. The first patent focuses on analyzing the activity of nucleases, such as ZFNs, TALENs, or CRISPR-associated nucleases, specifically their cutting at 'off-target' loci. The second patent relates to methods for analyzing guide RNA molecules, which are crucial for the effectiveness of gene editing techniques.
Career Highlights
Dawn Ciulla is currently associated with Editas Medicine, Inc., a leading company in the field of gene editing. Her work at Editas has positioned her as a key player in the development of cutting-edge biotechnological solutions.
Collaborations
Dawn collaborates with talented individuals such as Georgia Giannoukos and Christopher Wilson, contributing to a dynamic research environment that fosters innovation.
Conclusion
Dawn Ciulla's contributions to the field of nuclease analysis and her innovative patents highlight her role as a significant inventor in biotechnology. Her work continues to influence advancements in gene editing technologies.